Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-blocker treatment in heart failure.

A Bouzamondo1, J S Hulot, P Sanchez

  • 1Pharmacology Department, Pitié Salpêtrière Hospital, Paris, France.

Fundamental & Clinical Pharmacology
|July 27, 2001
PubMed
Summary

Beta-blockers significantly reduce hospitalizations and mortality in chronic heart failure patients. This established therapy, combined with other treatments, improves left ventricular function and prevents arrhythmias.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publication bias in pharmacogenetics of adverse reaction to antiseizure drugs: An umbrella review and a meta-epidemiological study.

PloS one·2022
Same author

Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance.

Annales de cardiologie et d'angeiologie·2021
Same author

Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis.

Thrombosis research·2020
Same author

Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytes.

Annales d'endocrinologie·2020
Same author

Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis.

Diabetes & metabolism·2019
Same author

Clomiphene citrate and neural tube defects: a meta-analysis of controlled observational studies.

BJOG : an international journal of obstetrics and gynaecology·2019

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Heart failure treatment has evolved, incorporating vasodilator therapy and understanding neuro-hormonal effects.
  • Beta-blockers, once contraindicated, are now vital in heart failure management.

Purpose of the Study:

  • To review clinical trials comparing beta-blockers versus placebo in chronic heart failure.
  • To assess the impact of beta-blockers on mortality, morbidity, and left ventricular function.

Main Methods:

  • Systematic review and meta-analysis of 16 randomized trials.
  • Inclusion of trials comparing beta-blockers (metoprolol, bisoprolol, bucindolol, carvedilol) with placebo in chronic heart failure.

Main Results:

  • Beta-blocker therapy showed good tolerance with dose increment.

Related Experiment Videos

  • Significant reductions in heart failure hospitalizations (24%) and mortality (22%) were observed.
  • Left ventricular function improved, and hospitalizations decreased.

    • Conclusions:

    • Beta-blocker treatment is an established, essential therapy for heart failure when used with diuretics and ACE inhibitors.
    • Mechanisms of benefit may involve improved left ventricular function and reduced arrhythmias.
    • Further research is needed to optimize beta-blocker strategies for individual patients.